JP2025510161A5 - - Google Patents
Info
- Publication number
- JP2025510161A5 JP2025510161A5 JP2024556499A JP2024556499A JP2025510161A5 JP 2025510161 A5 JP2025510161 A5 JP 2025510161A5 JP 2024556499 A JP2024556499 A JP 2024556499A JP 2024556499 A JP2024556499 A JP 2024556499A JP 2025510161 A5 JP2025510161 A5 JP 2025510161A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide compound
- solvate
- salt
- peptide
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263323831P | 2022-03-25 | 2022-03-25 | |
| US63/323,831 | 2022-03-25 | ||
| PCT/CA2023/050401 WO2023178449A1 (en) | 2022-03-25 | 2023-03-24 | Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510161A JP2025510161A (ja) | 2025-04-14 |
| JP2025510161A5 true JP2025510161A5 (enExample) | 2026-03-30 |
Family
ID=88099462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556499A Pending JP2025510161A (ja) | 2022-03-25 | 2023-03-24 | ガストリン放出ペプチド受容体（ｇｒｐｒ）のインビボイメージング及びｇｒｐｒ関連障害の治療のための放射性標識化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12246076B2 (enExample) |
| EP (1) | EP4499663A1 (enExample) |
| JP (1) | JP2025510161A (enExample) |
| KR (1) | KR20250007523A (enExample) |
| CN (1) | CN119213011A (enExample) |
| AU (1) | AU2023239751A1 (enExample) |
| CA (1) | CA3246188A1 (enExample) |
| IL (1) | IL315057A (enExample) |
| WO (1) | WO2023178449A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025054727A1 (en) * | 2023-09-13 | 2025-03-20 | Provincial Health Services Authority | Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843903A (en) | 1995-11-27 | 1998-12-01 | The Administrators Of The Tulane Educational Fund | Targeted cytotoxic anthracycline analogs |
| EP2100900A1 (en) | 2008-03-07 | 2009-09-16 | Universitätsspital Basel | Bombesin analog peptide antagonist conjugates |
| EP2198878A1 (en) | 2008-12-18 | 2010-06-23 | University Of Miami | Polypeptide bombesin antagonists |
| LT2900279T (lt) | 2012-09-25 | 2019-11-11 | Advanced Accelerator Applications Usa Inc | Grpr antagonistai, skirti grpr atžvilgiu teigiamo vėžio nustatymui, diagnozavimui ir gydymui |
| AU2019469641B2 (en) | 2018-11-13 | 2025-04-03 | Provincial Health Services Authority | Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders |
| TWI878344B (zh) * | 2019-09-17 | 2025-04-01 | 瑞士商諾華公司 | 放射性標記grpr拮抗劑之方法及其套組 |
-
2023
- 2023-03-24 EP EP23773418.1A patent/EP4499663A1/en active Pending
- 2023-03-24 AU AU2023239751A patent/AU2023239751A1/en active Pending
- 2023-03-24 IL IL315057A patent/IL315057A/en unknown
- 2023-03-24 CN CN202380029657.8A patent/CN119213011A/zh active Pending
- 2023-03-24 JP JP2024556499A patent/JP2025510161A/ja active Pending
- 2023-03-24 WO PCT/CA2023/050401 patent/WO2023178449A1/en not_active Ceased
- 2023-03-24 KR KR1020247035353A patent/KR20250007523A/ko active Pending
- 2023-03-24 CA CA3246188A patent/CA3246188A1/en active Pending
- 2023-11-17 US US18/512,708 patent/US12246076B2/en active Active
-
2025
- 2025-02-03 US US19/043,780 patent/US20250195702A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025161856A5 (enExample) | ||
| JP2022548875A5 (enExample) | ||
| JP2021530451A5 (enExample) | ||
| JP2021191784A5 (enExample) | ||
| JP2015212268A5 (enExample) | ||
| JP2021503490A5 (enExample) | ||
| JP2021100937A5 (enExample) | ||
| JP2024516371A5 (enExample) | ||
| CA2319672A1 (en) | Compounds and compositions for delivering active agents | |
| JP2010526089A5 (enExample) | ||
| JP2006514689A5 (ja) | １−オキソ−２−（２，６−ジオキソピペリジン−３−イル）−４−メチルイソインドリンを含む脳腫瘍の治療及び管理のための医薬組成物 | |
| JP2018538273A5 (enExample) | ||
| CN105436701B (zh) | 镁基金属与铝基金属的连接方法 | |
| Rainsford et al. | Gastric mucus effusion elicited by oral copper compounds: potential anti-ulcer activity | |
| JP2004519493A5 (enExample) | ||
| JP2015509079A5 (enExample) | ||
| JP2003534246A5 (enExample) | ||
| RU2734930C2 (ru) | Режимы дозирования мелфлуфена для раковых заболеваний | |
| JP2025507971A5 (enExample) | ||
| JP2022507214A5 (enExample) | ||
| JP2020524670A5 (enExample) | ||
| JP2024528127A5 (enExample) | ||
| JPH10147529A5 (enExample) | ||
| JP2007502303A5 (enExample) | ||
| JP2017532316A5 (enExample) |